Court filing
Defendant's Memorandum Re Probation Petition -- United States v. Aticha Jittaphol, a/k/a "Lily"
No. 1:21-cr-10270-MLW · Doc. 48 · Docket on CourtListener
Full text
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 1 of 10
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF MASSACHUSETTS
United States of America No. 21-CR-10270-MLW
v.
Aticha Jittaphol
DEFENDANT’S MEMORANDUM RE PROBATION PETITION
The Court should find that Probation has not established “probable cause
to believe that [Ms. Jittaphol] has committed a Federal, State or local crime while
on release,” and has failed to establish probable cause to believe that “there is no
condition or combination of conditions of release that will assure that [Ms.
Jittaphol] will not flee or pose a danger to the safety of any other person or the
community.” See 18 U.S.C. § 3148; United States v. Alfonso, 284 F.Supp.2d 193,
202 (D.Mass 2003). The Court should find that the positive sweat patch result
obtained on February 7th does not establish probable cause to believe that Ms.
Jittaphol used methamphetamine. Inpatient care should not be imposed. No
action should be taken on the petition submitted by Probation on February 7th.
Methamphetamine usually “can be detected in the urine … anywhere from
3 to 7 days following the last dose.” American Addictions Center, “How Long
Does Meth Stay in Your System,” December 30, 2021,
https://rehabs.com/blog/how-long-does-crytal-meth-stay-in-you-system/.
Christopher C. Cruickshank & Kyle R. Dover, A Review of the Clinical
Pharmacology of Methamphetamine, Addiction 104, 1085-1099 (2009)
(“Amphetamines might be expected to be present in the urine for extended
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 2 of 10
periods in the context of abuse … methamphetamine has been detected in urine 7
days after completing a regimen of 4 daily 10-mg doses …”).
Sweat patches will test positive based on drug use during any of the time that the
test is worn, typically one week. The positive sweat patch was removed on
January 20th. A negative urine test was conducted the following day. Thus, there
was significant overlap in the dates that these tests covered.
If Probation now maintains that Ms. Jittaphol should be placed in inpatient
residential care based on a single positive sweat patch test, that position is not
based on the facts, but on a willingness to ignore the facts in favor of a “we told
you so” mentality. This is illustrated by Probation’s readiness to disregard
inherent inconsistencies in its position.
Probation has asserted that inpatient care is needed because
methamphetamine is extraordinarily addictive. Ms. Jittaphol requested placement
in a detox because she recognized that she could not stop her daily use of
methamphetamine without help. Her subsequent treatment records include candid
discussion of her chronic, daily-use addiction. Methamphetamine is not a drug
that users take occasionally. It provides subjective effects for no more than four
hours, usually prompting addicts to take it several times a day. Daily use or
multiple day binges are routine. See Christopher C. Cruickshank & Kyle R. Dyer,
A Review of the Clinical Pharmacology of Methamphetamine,” Addiction 104,
1085-1099 (2009) (“Acute subjective effects diminish over 4 hours … [which]
may drive repeated use within intervals of 4 hours … a typical pattern of use
2
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 3 of 10
appears to consist of four doses daily, in binges lasting 4 days.”). Withdrawal
symptoms can be severe, including insomnia, depression, anxiety, cognitive
impairment, agitation, and methamphetamine craving. The absence of
methamphetamine withdrawal syndrome is associated with a greater likelihood of
avoiding relapse and is a significant criterion in assessing the need for inpatient
treatment. See Cruickshank & Dyer, id.; Report of Stuart Gitlow, M.D.,
previously provided. Ms. Jittaphol’s treatment records do not describe any
significant withdrawal symptoms.
Ms. Jittaphol has had at least six urine tests since January, about one per
week. Her first sweat patch was removed on January 14th. It tested negative. It was
replaced by a patch that was removed on January 20th that tested positive. She has
had at least three sweat patches tested since. The results have not been produced.
On February 11th, Probation produced results in its possession; the last being a
urine test from February 3rd. Despite repeated requests, Probation has not
produced any subsequent results. Given that the produced tests show urine results
obtained within a week, and patch results within two weeks, it is likely that
Probation has received results for at least two urine tests since February 3rd and
results for patches removed on January 27th and February 7th or 10th1. Additional
test results likely will be obtained prior to a hearing on this matter. Given that
Probation reported the single positive test immediately, it must be presumed that
all these tests were negative, since no subsequent positive test has been reported.
1
Ms. Jittaphol’s text messages with Ms. Wertz leave it unclear whether she went to court
for testing on February 7th or 10th.
3
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 4 of 10
An updated list of the tests since January is provided:
Type of Test Date of Sample Date of Result Result
Urine 1/11/22 1/18/22 Negative
Patch 1/14/22 1/27/22 Negative
Patch 1/20/22 2/7/22 Positive
Urine 1/21/22 1/27/22 Negative
Urine 1/26/22 2/1/22 Negative
Patch 1/27/22 not produced Presumed Negative
Urine 2/3/22 2/7/22 Negative
Urine 2/7/22 or not produced Presumed Negative
2/10/22
Patch 2/7/22 or not produced Presumed Negative
2/10/22
Urine 2/17/22 not produced Presumed Negative
Patch 2/17/22 not produced Pending
There is an obvious inconsistency in asserting that methamphetamine is so
addictive that Ms. Jittaphol needs inpatient care to avoid using but has managed
to use only sporadically since her release from The Hope Center, perhaps only
during the week prior to the positive sweat patch test, and perhaps only during
the early days of that week, which may not have been covered by urinalysis.
Ms. Jittaphol’s most recent urine test was February 17th. Once again, she
asked to be observed. Given Probation’s February 14th memorandum, stating a
willingness to perform observed urine screens so long as a male probation officer
4
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 5 of 10
was available, she had reason to believe that the sampling would be observed.
Instead, she again was told it was not necessary. Probation has not conducted any
observed tests. To the extent that Probation asserts that the urine tests are
unreliable, Probation has created and maintained this excuse by failing to conduct
supervised sampling despite Ms. Jittaphol’s repeated requests.
Any assertion that Ms. Jittaphol could manage to provide someone else’s
urine and get away with it every week this year is nonsensical. There is nothing
about Ms. Jittaphol to even remotely suggest that she could succeed at such
deception, or that she’d want to. Is someone looking at her before she goes into
the restroom to see if there’s a hidden bottle of urine? Or is Probation so inept, or
Ms. Jittaphol so sleightful, that week in and week out she’s able to hide the bottles
without getting caught? If she was bringing someone else’s urine into the
courthouse again and again, why would she repeatedly ask Probation to have
someone observe her urinate? If she’s using methamphetamine, this
extraordinarily addictive drug that routinely involves daily use, how do you
explain all the negative tests, including sweat patch tests? Rather than struggle to
come up with answers to these obvious questions, there is another obvious
explanation – the sole positive sweat patch test was wrong.
In Alfonso, 284 F.Supp.2d at 193, Judge Young discussed some of the
literature warning of the risk of false positives from sweat patch tests, and
literature documenting reliability problems with sweat patch testing has mounted
since. See Marilyn A Huestis, et al., Monitoring Opiate Use in Substance Abuse
5
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 6 of 10
Treatment Patients with Sweat and Urine Drug Testing, J Analytical Toxicology
24, 509-521 (2000) (“… 7.9% false-positive sweat results as compared to urine
tests.”); David A. Kidwell & Frederick P. Smith, Susceptibility of PharmChek
Drugs of Abuse Patch to Environmental Contamination, Forensic Science Intl
116, 89-106 (2001) (“ … normal hygiene did not remove all drugs from
externally contaminated skin [of drug-free subjects] and positive sweat patches
resulted.”); Joseph A. Levisky, et al., Comparison of Urine to Sweat Patch Test
Results in Court Ordered Testing, Forensic Science International 122, 65-68
(2001) (a “… high incidence of false positive sweat patch tests,” referencing
studies reporting false positive rates of 21.1% in cocaine detection and 7.9% in
opiate detection.); Melissa Long & David A. Kidwell, Improving the Pharmcheck
Sweat Patch: Reducing False Positives from Environmental Contamination and
Increasing Drug Detection, Dept of Justice Final Report (2002) (“Urine tests on
individuals have shown urine negative/patch positive results with close contact
with a drug-contaminated environment. Several cases have involved individuals
identified as methamphetamine positive who denied any methamphetamine use,
while admittedly using other drugs. The individuals involved in these cases were
all in environments where profuse sweating was common …”); D. A. Kidwell, et
al., Comparison of Daily Urine, Sweat, and Skin Swabs Among Cocaine Users,
Forensic Sci Int 133 (1-2), 63-78 (2003) (“… patch results may represent current
use, prior use, contamination, or a combination … false positives occurred at a
7% rate.”); Marek C. Chawarski, et al., Utility of Sweat Patch Testing for Drug
6
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 7 of 10
Use Monitoring in Outpatient Treatment for Opiate Dependence, J Subst Abuse
Treat 33(4), 411-415 (2007) (“… sweat testing is less sensitive than weekly urine
testing in detecting opiate use;” “… precautionary measures, including cleansing
the skin before patch application are not completely reliable in preventing
contamination …”); N. De Giovanni & N. Fucci, The Current Status of Sweat
Testing for Drugs of Abuse: A Review, Current Medicinal Chemistry 20, 545-
5671 (2013) (“For chronic users it is not clear whether a cocaine appearing in the
patches came from current drug ingestion, previous drug ingestion, previous drug
contamination, current drug contamination, or a combination of the above … The
effects of vigorous or prolonged exercise on the transfer of drugs into sweat
and/or the disposition of these drugs onto the patch are unknown and there is
evidence that outward transdermal migration of some accumulated drugs may
lead to an incorrect interpretation of new drug use.”); Joy N. Hussain, et al.,
Working Up a Good Sweat – The Challenges of Standardizing Sweat Collection
for Metabolomics Analysis, Clin Biochem Rev 38, 13-38 (2017) (Sweat from
exercise may have a different metabolic content, and may impact test results).
Ms. Jittaphol sometimes strenuously exercises. The Fucci, Long, Huestis
and Hussain articles referenced above each describe or suggest a risk of higher
rates of false positive sweat patch results amongst past drug users where there is
an increase in sweating caused by vigorous exercise.
In Alfonso, there were six positive sweat patch tests. Judge Young dismissed
two as unreliable based on the way the patches were removed. He emphasized the
7
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 8 of 10
significance of the remaining four positive tests: “[t]he Court deems it important to
note that it was the aggregate of positive results that provided probable cause to
believe that Alfonso used cocaine while on supervised release.” Alfonso, 284
F.Supp.2d at 204. In this case, not only is there only one positive test, but that test
is inconsistent with all the other tests, including a negative urine test that
overlapped part of the time when the positive sweat patch was worn, and involves
a drug that is less likely to be used sporadically than cocaine.
Probation has never addressed the assertion that a recommendation for
long-term inpatient was improper from the start and a deviation from the standard
of care. Probation has never disputed that The Hope Center failed to assess
whether such care was warranted. Never disputed that the clinical supervisor in
charge of Ms. Jittaphol’s care at The Hope Center, Hilary Moody, stated that The
Hope Center did not assess whether inpatient residential care was appropriate
because it understood that the treatment plan had been dictated by Probation’s
P45 form, which was interpreted as a “contract” requiring long-term residential
care. Never disputed that Ms. Moody acknowledged that Ms. Jittaphol did not
meet the criteria applied to determine whether inpatient care is warranted. Never
disputed that Probation’s recommendation for inpatient treatment was based on
the recommendation of The Hope Center, not on any independent assessment,
because Probation is not qualified to make such an assessment, and that The Hope
Center’s recommendation, in turn, was based on a misinterpretation of the P45
form, not on a clinical assessment. Never disputed any of the facts or opinions
8
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 9 of 10
stated by Dr. Stuart Gitlow in his letter concluding that the recommendation for
inpatient residential care was a breach of the standard of care, lacked support in
clinical findings, and was unsupported by treatment record documentation of any
of the criteria deemed essential to warrant inpatient residential care.
Even if the one positive sweat patch test was legitimate, that alone would
not justify inpatient care, given all the other negative tests. There has never been a
clinical assessment of the need for inpatient treatment, and there should be no
consideration of inpatient treatment unless a qualified care provider finds it
appropriate. At that point, Ms. Jittaphol should have an opportunity to challenge
such a finding. However, a single positive sweat patch test does not establish
probable cause to believe that Ms. Jittaphol used methamphetamine. There is
ample reason to find it likely that the positive test was false. No action should be
taken on Probation’s petition and Ms. Jittaphol should not be required to
participate in inpatient treatment. She does not object to outpatient counselling
and has worked with Probation to arrange it. The Court should accept the parties’
“C Plea,” and to the extent that a qualified clinician believes that outpatient
counselling is warranted for Ms. Jittaphol to maintain sobriety, this would be an
appropriate condition of Probation.
ATICHA JITTAPHOL
By her Attorney,
/s/ Keith Halpern
Keith Halpern, BBO # 545282
572 Washington Street, Suite 19
Wellesley, MA 02482
(617) 722-9952
9
Case 1:21-cr-10270-MLW Document 48 Filed 02/23/22 Page 10 of 10
CERTIFICATE OF SERVICE
I hereby certify that this document, filed through the ECF system, will be sent
electronically to the registered participants as identified on the Notice of Electronic Filing
(NEF) and paper copies will be sent to those indicated as non-registered participants on
February 23, 2022.
/s/ Keith Halpern
10
File and source
- File
- gov.uscourts.mad.237964.48.0.pdf
- Size
- 207,454 bytes
- SHA-256
- f638a61cfe2eba1691e51ec1bddc6df8836f0b01e149fbbac639fd77774aff29
- Our copy
- gov.uscourts.mad.237964.48.0.pdf
- Original
- PACER (login required)